The burgeoning virtual marketplace has presented novel avenues for accessing prescription drugs, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While supporters of cognitive enhancement argue that these substances can boost focus and productivity, ethical concerns arise surrounding the a